They are focused on discovering and developing gut-restricted, small molecule therapeutics for CNS disorders, aiming to improve the quality of life for individuals with CNS diseases and disorders. By leveraging their expertise in the gut-brain axis and unique drug development platform, Axial Therapeutics aims to transform the treatment paradigm in neurodegenerative diseases, offering hospitals a fresh approach to diagnose and treat CNS diseases.